In atopic dermatitis (AD), a chronic inflammatory skin disease, characterized by eczematous skin lesions, intense pruritus, epidermal barrier defects, and by a dysregulation of the immune system [12–14], an increase of GZMB expression in CD4+ and CD8+ T cells was observed. This evidence concerns the gene GZMB and atopic eczema.